Objectives: The purpose of this paper was to systematically evaluate the effectiveness of non-surgical therapy for the treatment of peri-implant diseases including both, mucositis and peri-implantitis lesions. Material and Methods: An electronic search in two different databases was performed including MEDLINE (PubMed) and EMBASE from 2011 to 2016. Human studies reporting non-surgical treatment of peri-implant mucositis and peri-implantitis with more than 10 implants and at least 6 months follow up published in English language were evaluated. A systematic review was performed to evaluate the effectiveness of the different methods of decontamination employed in the included investigations. Risk of bias assessment was elaborated for included investigations. Results: Twenty-five articles were identified of which 14 were further evaluated and included in the analysis. Due to significant heterogeneity in between included studies, a meta-analysis could not be performed. Instead, a systematic descriptive review was performed. Included investigations reported the used of different methods for implant decontamination, including selfperformed cleaning techniques, and professionally delivered treatment such as laser, photodynamic therapy, supra-/submucosal mechanical debridement, and air-abrasive devices. Follow-up periods ranged from 6 to 60 months. Conclusions: Non-surgical treatment for peri-implant mucositis seems to be effective while modest and not-predictable outcomes are expected for peri-implantitis lesions. Limitations include different peri-implant diseases definitions, treatment approaches, as well as different implant designs/surfaces and defect characteristics.
INTRODUCTION
During the last decades the definition of periimplantitis has suffered several modifications with the development in the understanding of dental implantology and its biological implications. Recently, as described by the American Academy of Periodontology [1] mucositis is defined as an inflammatory process around a dental implant without loss of supporting bone beyond biological bone remodelling. On the other hand, periimplantitis is characterized by both, inflammation of the surrounding peri-implant tissues and loss of supporting bone beyond initial biological bone remodelling. Nonetheless recent investigations have recognized at least 7 definitions of peri-implantitis based on the extension and severity of the bone loss [2] . These interpretations of the peri-implant disease certainly reflect the multifactorial nature of the entity, displaying a multitude of clinical presentations. Hence, it is reasonable to assume that further definitions will appear in upcoming years as we continue performing research in the field. Nonetheless, the complex mechanisms that influence initial bone remodelling, among other variables, will certainly ensure this to be a challenging duty. With regard to the treatment of the peri-implant diseases, a variety of different approaches have been proposed including but not limited to: non-surgical therapy; surgical management by means of access flap debridement, lasers disinfection, implantoplasty, resective procedures, as well as regenerative approaches [3] . While most of the available evidence agrees on the effectiveness of non-surgical therapy for mucositis lesions [4] , conflicting results are found when trying to identify the most effective protocol for peri-implantitis [3, 5] . In this sense, a recent systematic review evaluating the effectiveness of periimplantitis treatment has shown that reconstructive procedures do not result in more optimal outcomes when compared to non-reconstructive procedures [5] . This result is in concordance with the majority of the literature available with regard to peri-implantitis treatment which presents with great variability in terms of treatment outcomes. These inconsistencies can be attributed to a variety of different factors, including but not limited to: different aetiologies and contributing factors affecting dental implants, morphology of the defects, case description/selection, implant positioning, and the influence of different implant surfaces. Non-surgical therapy for peri-implant diseases has traditionally been considered effective for mucositis.
However, results for peri-implantitis lesions were found not to be effective [4] . Surprisingly, newer studies have challenged again this hypothesis achieving exceptional results after non-surgical decontamination of peri-implantitis lesions [6] . Due to the increasing prevalence of both peri-implant mucositis and peri-implantitis, there is an urgent need to understand its aetiology and the multiples variables affecting it development and progression leading to the generation of more predictable treatment approached. Hence, the aim of the present review was to systematically evaluate the effectiveness of current (last 5 years) methodologies for the non-surgical treatment of peri-implant diseases.
MATERIAL AND METHODS Protocol and registration
The methods as well as inclusion/exclusion criteria employed for the present review were determined in advance. This protocol was registered in an international prospective register of systematic reviews 'PROSPERO' with the following registration number: CRD42016037631. The current systematic review was performed by two independent reviewers following the PRISMA guidelines for identification, screening, eligibility, and inclusion [7] .
Focus question
The following focus question was developed according to the population, intervention, comparison, and outcome (PICO) study design: In patient suffering from peri-implant mucositis or peri-implantitis, what is the effectiveness of non-surgical therapy by means of different techniques and/or approaches for clinical and radiographically resolution of disease, including bleeding on probing (BOP), probing pocket depth (PPD), and radiographic bone (RB) level changes.
Information sources
The search strategy consisted in the examination of several databases as well as manual screening. The electronic search was performed in several databases, including MEDLINE (PubMed), and EMBASE databases for articles from 2011 up to April 2016 with limitation to English language. Additionally, a manual search of periodontics/implantology-related journals, including "Clinical Oral Implant OR "peri-implant mucositis") OR "peri-implant maintenance") OR "implant infection") OR "peri-implant infection" AND ("last 5 years"
[PDat] AND "Humans" [Mesh] ). On the other hand, for EMBASE for following terms were employed: "non-surgical"' OR "scaling"' OR "laser/exp" OR "laser" OR "subgingival curettage/exp" OR "subgingival curettage" AND ("periimplantitis/exp" OR "'periimplantitis") OR "peri-implant mucositis".
Selection of studies
Titles and abstracts derived from the search were independently screened by two reviewers (FSLA and SHY) based on the inclusion criteria. Both reviewers compared decisions and their eligibility for this review was confirmed after discussion. Full articles were obtained for all the investigations deemed eligible for inclusion in this paper and further evaluated by both reviewers. If needed, a third party was consulted when consensus could not be reached.
Types of publications
The present review included only human studies published in the English language. Letters, editorials, reviews and meta-analysis, PhD thesis, as well as abstracts were not evaluated.
Types of studies
The present investigation included cases series, prospective, as well randomized controlled trials (RCTs) published between 2011 and April of 2016 that reported on non-surgical treatment for periimplant mucositis and peri-implantitis. Case report, retrospective, as well as studies with less than 10 implants or less than 6 months follow up were excluded.
Types of participants/population
Individuals included in the studies should have had at least one osseointegrated screw-type dental implant that presented with signs of peri-implant mucositis or peri-implantitis and received non-surgical treatment. Nonetheless, included investigations presented with different definitions for the diseases evaluated.
Inclusion and exclusion criteria
Articles were included in this systematic review if they met the following inclusion criteria:
• Investigated non-surgical treatment outcomes for peri-implant mucositis and peri-implantitis in patients with at least one osseointegrated solid screw-type implant; • All human prospective studies, as well as clinical trials, cohort studies, case-control, and case series studies; • At least 10 implants; • At least 6 months follow-up; • Clinical and/or radiographic changes reported.
Treatment outcomes reporting changes in PPDs and/or BOP and/or RB changes. On the contrary, the following articles were excluded:
• Care reports, retrospective investigations, in vitro and animal studies; • Less than 10 implants; • Less than 6 months of follow-up;
• Surgical treatment for peri-implantitis;
• Human trials with missing information or unclear data.
Sequential search strategy
Initial literature search was conducted in several databases including MEDLINE (PubMed) and EMBASE from 2011 to 2016. All articles titles were screened in order to eliminate non-qualifying studies. Next, screening of abstract was performed followed by elimination of non-qualifying investigations. Finally, full text evaluation of each article was performed in order to confirm the eligibility based on the inclusion and exclusion criteria. 
Data extraction
Data were extracted from the included studies independently by two reviewers (FSLA and ESHY). If any disagreement occurred, a third reviewer was consulted (HLW).
Assessment of methodological quality
The quality of all selected RCTs was assessed using The Cochrane Collaboration's tool for assessing risk of bias in randomised trials [8] . Parameters evaluated included:
• Random sequence generation;
• Allocation concealment;
• Blinding of participants and personnel;
• Blinding of outcome assessment;
• Incomplete outcome data;
• Selective reporting;
• Other bias. The potential risk of bias was categorized as "low", "unclear" or "high" depending on the quality and detailed explanation of provided information about all abovementioned parameters. All assessments were completed by a single examiner (SHY). The Newcastle-Ottawa Scale (NOS) was used to evaluate the methodological quality of nonrandomized included studies [9] . The topics evaluated were selection of study groups, comparability of patients, and outcome. Each included study received a maximum of 10.
Data analyses
Significant heterogeneity between publications in terms of diseases definitions, study designs, patient and defect related characteristics, as well as measured outcomes, among others, prevented the quantitative synthesis of the included studies and consequently a meta-analysis could not be completed. Instead, a qualitative descriptive analysis of the reported outcomes was performed and systematically reviewed in forms of tables.
RESULTS

Study selection
Initial screening of electronic databases yielded a total of 2837 articles. Additionally, 21 more articles were found through manual screening. After removal of duplicated studies, a total of 2625 titles and abstract were evaluated. Overall, a total of 26 potentially relevant articles were selected after an evaluation of their titles and abstracts. Full text of these articles was obtained and thoroughly evaluated. Of these, 14 studies fulfilled the inclusion criteria and were subsequently included in the systematic review ( Figure 1 and Tables 1 -2 ).
Excluded studies
The reasons for exclusion are summarized in Table 3 . Four articles presented with short follow up with less than 6 months [10] [11] [12] [13] , two articles were retrospective in design [6, 14] , one investigation was a review study [15] , three articles employed the same study population than other included investigations in the present analysis [16] [17] [18] , and 1 investigation presented with unclear and incomplete data [19] .
Study characteristics
The characteristics of the 14 included articles are summarized in Tables 1 and 2 . The publications include several study types: 9 randomized controlled trials (RCTs) with parallel designs [20] [21] [22] [23] [24] [25] [26] [27] [28] , 1 singlearmed cohort study [29] , 4 non-controlled prospective studies and case series [30] [31] [32] [33] . The follow-up periods of the studies ranged from 6 to 60 months. There were several different definitions regarding periimplant mucositis and peri-implantitis, being the definitions for peri-implantitis more variable than those of mucositis. In the Deppe et al. [32] study, they classified peri-implantitis into moderate and severe groups based on the severity of the bone loss. Most articles reported the subject numbers as well as the implants evaluated in the studies, however 3 articles failed to report the numbers of the implants that were evaluated in the studies [23, 24, 27 ] while 1 article only presented the mean number of implants for each patient [28] .
Regarding the description of the diseased sites, most studies provided information on PPD and BOP of the affected implants, however, 2 articles did not present PPD for the implants affected by mucositis [30, 33] . Eleven articles reported RB loss [20] [21] [22] [23] [24] [25] [26] [27] [28] 32, 33] . Some articles reported on
the implant characteristics including the systems and the surface materials, implant functioning time and the prosthetic design [20] [21] [22] [23] [24] [27] [28] [29] 31, 33] . One study particularly excluded implants with titanium plasma sprayed or hydroxyapatite coated implants [25] . Five articles performed microbial test [20, 21, 23, 26, 28] .
Some articles reported the locations (i.e. maxilla or mandible; anterior or posterior) of the implants evaluated in the studies, however, none of the articles presented the bucco-lingual position of the implants and no articles reported the possible aetiology and/or contributory factors of peri-implant mucositis or peri-implantitis. NCBI PubMed and PMC advanced search: -Search terms: PubMed library, combinations of controlled terms (MeSH and EMTREE) and keywords were used whenever possible. Into the addition, other terms not indexed as MeSH and filters were applied. As such, the key terms used were: ((((((((((((("non- Full-text articles excluded, with reasons (Table 3 No short-term differences between groups. The clinical improvements observed at 6 months may be attributed to improvements in oral hygiene.
No evidence for the use of systemic antibiotics in treatment of peri-implant mucositis. Test MD with titanium curettes + polishing + ABX (Azithromycin® 500 mg day 1 and 250 mg days 2 -4). 
Treatment interventions of individual studies
Most of the studies included oral hygiene instructions of using interdental brushes or other required techniques indicated in the protocol before initiating different treatment modalities [20, 21, [23] [24] [25] [26] [27] [31] [32] [33] . One study reported self-performed cleaning techniques including certain toothpaste and toothbrush [28] . One article presented the model of systemic administration of antimicrobial agent [23] while Bassetti et al. [21] in 2014 reported the effect of locally delivered antibiotics adjunct to scaling and root planning (SRP) and air-polishing; and another article evaluated the effect of chlorhexidine chip (Perio ® chip) in treating peri-implantitis [25] . Of importance to mention is that Bassetti and colleagues [21] repeated the treatment in BOP positive sites after 3, 6, 9, and 12 months. Other professional-performed interventions that were presented in the articles include laser, photodynamic therapy, supra-/submucosal mechanical debridement, and air-abrasive devices. Four articles reported the use of lasers in conjunction to SRP [20, 22, 26, 33] . Lasers employed were diode laser [20] , Er:YAG laser [26, 33] and lightactivated disinfection treatment (FotoSan). Three other articles reported on photodynamic therapy [21, 22, 32] .
Treatment outcomes
PPD was reported as direct or the percentage change except one article [27] . Majority of studies demonstrated that the change of PPD are within 1 mm. Bleeding index or the percentage of BOP also decreases after different treatment modalities in most of the studies. Regarding the laser studies, 3 studies showed that there were no additional positive effect beyond the traditional mechanical debridement and had limited influence in treating peri-implantitis [20, 22, 26] while other one article presented significant clinical improvement [21] . Regarding selfperformed hygiene techniques, most of the studies demonstrated that with the application of hygiene protocol, it is effective to improve clinical parameters and also keeping the low incidence of developing peri-implant mucositis [28] . For professionalperformed mechanical debridement, studies in general demonstrated effectiveness in reducing inflammation and PPD [24, 27, [30] [31] [32] .
Assessment of methodological quality
The results of risk of bias assessment for included RCTs were summarized in Table 4 . In addition, 6 studies were non-RCT and qualitative assessments were analysed with NOS. The mean NOS score for the evaluated studies was 6 ± 1.
DISCUSSION
Dental implants have become the gold standard when aiming at reconstruction of the missing dentition. Decades of investigation have proven dental implants to be reliable alternative providing function and aesthetics with long-term success. However, with the increasing number of fixtures being installed yearly, there has also been a significant increase in the number of patients suffering from peri-implant diseases. According to a recent systematic review peri-implant mucositis and peri-implantitis have a prevalence ranging from 19 to 65% and from 1 to 47%, respectively. On the other hand, mean prevalence for peri-implant mucosistis and periimplantitis are 43% and 22%, respectively [34] . Consequently, treatment of peri-implant diseases has become one of the main focus of the investigations in periodontology. During the last decades, this inflammatory condition has witnessed a tremendous advance in terms of understanding of its aetiology as well as the surgical management. As an example, studies focusing on the different aspects of this disease have been multiplied by more than 100 times during the last two decades. While initially thought as a periodontitis like lesion surrounding a dental implant, peri-implantitis has recently been related to multiple other variables. In fact, there are a great variety of factors that have been related with marginal bone loss (MBL) and/or periimplantitis that often differ with the ones associated with periodontitis. To name a few: surgical trauma, infection, plaque and poor oral hygiene, alcohol and tobacco consumption, as well as biological bone remodelling [35] [36] [37] [38] . Moreover, the possible existence of an imbalance between the implant fixture and the surrounding bone has recently been proposed as a possible etiological factor. Although solely based on narrative reviews [39] , the hypothesis of a foreign body reaction as another causative agent for MBL has also been proposed [40] . In addition, the influence of the different implant surfaces and the presence of titanium particles embedded into the surrounding periimplant tissues have been recently investigated.
Regardless of the aetiology of the peri-implant diseases, multiple investigations are being conducted trying to elucidate the most effective treatment approach. However, while the determination of the most effective treatment seems a challenging duty and over the years conflicting results have been shown, the importance of prevention for prompt intervention seems to be in agreement by researchers. Today, the prevention as well as early detection of peri-implant mucositis remains as key components in successful dental implantology. These statements are supported by the effectiveness in treatment of mucositis while treatment of peri-implantitis remains unpredictable. Consequently, current evidence shows that periimplant mucositis can be successfully treated by nonsurgical therapy. Locally delivered antibiotics, lasers, mechanical sub-and supra-gingival SRP, as well as air-polishing, among others can be used for the non-surgical treatment of peri-implant mucositis. In addition, repeated treatment of diseased sites seems to be effective. Substantial improvements are to be made in research regarding treatment of peri-implantitis and periimplant mucositis. It is of paramount importance the identification of both local and systemic factors affecting the incidence and severity of such conditions for the proper management. Now a day, most of the investigations have failed to provide proper documentation with regard to implant system and position, which have been demonstrated to be significant contributing factors influencing the clinical outcome of different treatment modalities. Moreover, depending on the presence and severity of these local and systemic factors, in many instances, the treatment of choice should be explanation of the fixture.
Limitations
Within the limitation of the present investigations, the major drawback is the multitude of different definitions regarding peri-implant mucositis and peri-implantitis that were employed in the included investigations. Also, multiple different treatment approaches, different implant designs as well as surface characteristics, and wide variation in terms of follow-up periods may have played a role in the treatment outcomes. 
